CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Exercise or conversion Director acquired 12,758 shares (option exercise)
- 4 Open-market buy President and CEO bought 10,000 shares at $4.60 ($46,000)
- 4 Exercise or conversion President and CEO acquired 100 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 2,786 shares at $6.51 ($18,138)
- 4/A Open-market sale SVP Reg. & Quality sold 10,886 shares at an average $6.01 ($65,428)
- 4/A Open-market sale Chief Legal Officer sold 10,783 shares at an average $6.01 ($64,762)
- 4/A Open-market sale President and CEO sold 45,459 shares at an average $6.00 ($272,708)
- 4/A Exercise or conversion Chief Scientific Officer acquired 29,334 shares (option exercise)
- 4 Open-market sale SVP Reg. & Quality sold 10,886 shares at an average $6.01 ($65,428)
- 4 Open-market sale Chief Legal Officer sold 10,783 shares at an average $6.01 ($64,762)
- 4 Open-market sale Chief Commercial Officer sold 5,979 shares at $5.90 ($35,274)
- 4 Open-market sale President and CEO sold 45,459 shares at an average $6.00 ($272,708)
- 4 Open-market sale Chief Financial Officer sold 7,690 shares at an average $6.26 ($48,128)
- 4 Exercise or conversion Chief Scientific Officer acquired 29,334 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 9,890 shares at an average $5.96 ($58,977)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 2,783 shares at $5.86 ($16,313)
- 4 Open-market sale Chief Financial Officer sold 2,783 shares at $5.59 ($15,563)
- 4 Exercise or conversion President and CEO acquired 150,000 shares (option exercise)
Page 15 of 36 · 701 filings